Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThe outer thigh is one of three approved sites for a Wegovy leg injection, alongside the abdomen and upper arm. Clinical guidance confirms all three are equivalent in terms of medicine delivery, so the leg is a perfectly valid and commonly used option. Wegovy (semaglutide) is a prescription-only medicine requiring clinical assessment before it can be prescribed.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The Wegovy Summary of Product Characteristics, published on the electronic Medicines Compendium, specifies subcutaneous injection into the abdomen, the thigh or the upper arm. No single site is ranked above the others for efficacy. The STEP 1 trial (published in the New England Journal of Medicine and the basis for Wegovy's UK licence) used all three sites across its participants without differential outcomes. That means the leg is not a compromise; it is a clinically validated choice.
The thigh site means the outer, front-facing part of the upper leg. The inner thigh and the back of the leg are off-limits: the inner thigh has more blood vessels close to the surface, and the back is almost impossible to see clearly during injection. Aim for the middle third of the outer thigh, roughly midway between the knee and the hip crease. That region typically has enough subcutaneous fat, avoids the muscle beneath, and stays accessible whether you are sitting or standing.
Subcutaneous depth matters. Pressing the skin lightly (some people use a gentle pinch) lifts the fatty layer away from the muscle. The Wegovy pen needle is designed for subcutaneous delivery and does not need to be angled; hold the pen at a 90-degree angle to the skin and press the injection button. You can read step-by-step technique detail in our guide on how to inject Wegovy in the leg.
Rotation is not optional. Injecting into the same few centimetres week after week causes lipohypertrophy: the subcutaneous fat thickens and hardens in response to repeated needle trauma. The change is gradual and painless, which is why people often miss it. But semaglutide is absorbed more slowly through damaged tissue, which can make dosing unpredictable.
A simple rotation plan prevents it. Within the thigh, shift each injection by at least two centimetres from the previous spot. Many people split the outer thigh into a loose grid of eight to ten positions and work through them in order. Once you return to the start, the tissue has had enough time to recover. The same principle applies across sites: if you alternate between the leg and the abdomen, each individual spot gets two weeks' rest.
You do not have to use the same site each week. Mixing sites freely is fine as long as you are not doubling back to the same small area too quickly. Our page on where to inject Wegovy in the leg covers the exact zones to use and the areas to avoid. For a broader look at all three sites and how to choose between them, the Wegovy injection guide on the site sets it out clearly.
A few habits make the leg site more comfortable. Let the pen reach room temperature before injecting: a cold pen from the fridge door can sting more than one that has been sitting out for thirty minutes. Clean the skin with an alcohol swab and let it dry completely before pressing the pen to the skin, wet alcohol on the needle track stings.
After the injection, apply gentle pressure to the site with a clean finger or cotton ball for five to ten seconds. Do not rub. Some people see a small red mark or feel mild tenderness; that is normal and usually settles within a day. Bruising is more likely if the needle catches a small capillary, not because the thigh is a worse site but because it happens occasionally at any site.
After use, the pen needle should go straight into a sharps container, not the bin, not a bottle cap. Arrange collection through your council or return it to a pharmacy.
The NHS guidance on semaglutide (Wegovy) covers injection basics and side-effect management at a patient level. For questions specific to your dose or skin reactions, your prescriber or pharmacist is the right first call.
Injection-site reactions are the most common localised side effects: redness, itching, bruising or a small lump. Most resolve within a few days. Rotating the site and changing the needle with every injection are the two most effective ways to reduce them. Reusing a needle blunts the tip and increases discomfort and tissue trauma.
Systemic side effects are not site-specific. Nausea, loose stools, constipation and fatigue are tied to the medicine's mechanism rather than where on the body you inject. They tend to be most noticeable in the first few weeks or after a dose increase, and they often improve once your body adjusts. If you are still deciding which treatment suits you, our page covering weight loss injections including Ozempic sets out how the available options compare. The Wegovy injections overview covers the full side-effect profile in more detail.
Seek medical attention promptly for: persistent or severe stomach pain that radiates to the back (a possible sign of pancreatitis), a hard lump at an injection site that does not fade within a week or two, or any sign of an allergic reaction such as swelling, rash or difficulty breathing. You can report unexpected reactions using the MHRA's Yellow Card scheme, patient reports contribute to ongoing safety monitoring of newer medicines like Wegovy.
If any of this raises questions about whether Wegovy is the right option for you, or how your current rotation plan compares to what our prescribers see in practice, you can find full product and dosing information on our Wegovy injection page before booking the free consultation. A real clinician reads your answers the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.